Name | QX-314 (bromide) |
---|---|
Synonyms |
Hepato-Scan
Lidofenin 2,6-dimethylacetanilideiminodiacetic acid Ellipticine Lidocaine N-ethyl bromide Hida |
Description | QX-314 bromide is a membrane-impermeable permanently charged sodium channel blocker[1]. |
---|---|
Related Catalog | |
Target |
sodium channel[1] |
In Vitro | QX-314 bromide exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels (TRPV1) in vitro [1]. QX-314 bromide (1–60 mM) directly activates TRPV1 in a concentration-dependent manner[1]. QX-314 bromide (≥ 30 mM) produces oocyte membrane blackening and cell death [1]. QX-314 bromide inhibits calcium currents in hippocampal CA1 pyramidal neurons intracellular, and the low-threshold (T-type) Ca2+ currents are on average < 10% of control amplitude [3]. QX-314 bromide shifts the current-voltage relationships (I-Vs) in the positive voltage direction due to the presence of intracellular Br- [3]. |
In Vivo | QX-314 bromide (1.6 mg/kg; i.c.) abolishes responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin[2]. Animal Model: Male Sprague-Dawley rats (250-290 g)[2] Dosage: 1.6 mg/kg Administration: Intracutaneous injection Result: Abolished responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin. |
References |
Molecular Formula | C16H27BrN2O |
---|---|
Molecular Weight | 343.30200 |
Exact Mass | 342.13100 |
PSA | 29.10000 |
LogP | 0.19540 |
~% 24003-58-5 |
Literature: Loefgren; Fischer Svensk Kemisk Tidskrift, 1946 , vol. 58, p. 219,229 |